Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
10.1016/j.braindev.2014.11.005 144
Removal from Category 2 does not automatically grant Category 1 status
Although the use of exosomes as a delivery system has its drawback (for example, quickly eliminating by the reticuloendothelial system, lack of efficient encapsulation methods, and potential immune responses), exosomes targeted at tumors may allow systemic administration of miRNA as cancer treatment and are thus worthy of attention
Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells
Chronic disease claims lack evidence
US$ 27.76
US$ 23.96
US$ 22.10
US$ 22.43
